Connie Kasari is professor of human development and psychology at the University of California, Los Angeles. She is the principal investigator for several multi-site research programs and a founding member of the university’s Center for Autism Research and Treatment.
Connie Kasari
From this contributor
How much behavioral therapy does an autistic child need?
People tend to believe that, regardless of the treatment, more is always better. But is it?
How much behavioral therapy does an autistic child need?
Learning when to treat repetitive behaviors in autism
Some restricted and repetitive behaviors may have hidden benefits for people with autism, so scientists should work to find a happy medium between acceptance and change.
Learning when to treat repetitive behaviors in autism
School’s in
School-based interventions are arguably the best way to reach the truly underserved, under-represented and under-resourced children with autism, says Connie Kasari.
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.